Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 12, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Expands GALE-401 Intellectual Property Protection with Patent Issuance in Japan

SAN RAMON, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and...
September 09, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

SAN RAMON, Calif., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and...
August 09, 2016 16:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update

Advancing GALE-401 (Anagrelide CR) into a pivotal trial for the treatment of essential thrombocythemiaClosing NeuVax Phase 3 PRESENT trialNeuVax combination trials with trastuzumab continueWebcast...
July 26, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Report Second Quarter 2016 Financial Results and Provide a Corporate Update on Tuesday, August 9, 2016

SAN RAMON, Calif., July 26, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
July 13, 2016 16:35 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Closing of Registered Direct Offering

SAN RAMON, Calif., July 13, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
July 08, 2016 07:35 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Host Webcast and Conference Call Today

SAN RAMON, Calif., July 08, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
July 08, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Pricing of Registered Direct Offering

SAN RAMON, Calif., July 08, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
June 29, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitoring Committee Recommendation

SAN RAMON, Calif., June 29, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
June 13, 2016 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Presents GALE-401 Combined Safety Data at the European Hematology Association 21st Congress

SAN RAMON, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
June 10, 2016 14:46 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302

SAN RAMON, Calif., June 10, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...